Open access
Open access
Powered by Google Translator Translator

Cohort Study: Optimizing both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.

23 Jun, 2022 | 10:01h | UTC

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease – Annals of Rheumatic Diseases (link to abstract – $ for full-text)

Commentary: Low-dose glucocorticoids show no negative impact on BMD – medwire News

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.